Human papillomavirus (HPV) vaccines

Routine vaccination:

• Minimum age: 9 years
• HPV4 [Gardasil®] and HPV2 [Cervarix®] are licensed and available.
• Only 2 doses of either of the two HPV vaccines (HPV4 & HPV2) for adolescent/preadolescent girls aged 9-14 years, the doses are administered in 0-6 months schedule.
• For girls 15 years and older, and immunocompromised individuals 3 doses are recommended. The schedule is HPV4 (0, 2, 6 months) or HPV2 (0, 1, 6 months)
• For two-dose schedule, the minimum interval between doses should be 5 months.
• HPV4 is not yet licensed for use in males in India.
• The vaccine series can be started beginning at age 9 years.
• The minimum acceptable interval, in a 3-dose schedule is 4 weeks between dose 1 and dose 2 and 12 weeks between dose 2 and dose 3.

Catch-up vaccination:

• Administer the vaccine series to females (either HPV2 or HPV4) at age 13 through 45 years if not previously vaccinated.

Use recommended routine dosing intervals (see above) for vaccine series catch-up.